Global Varicose Vein Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• May 2022, THERACLION, a pioneering business creating a scalable robotic platform for non-invasive echotherapy, announced the release of SONOVEIN HD. This innovative technology combines the first and only extracorporeal therapeutic ultrasound treatment with cutting-edge imaging capabilities from SuperSonic Imagine, a French company based in Aix-en-Provence that Hologic just purchased.

• April 2022, I-VASC, a medical device company based in Italy, closed a Series A investment worth EUR 1.8 million to bring up its VELEX device, which is used for the treatment of varicose veins.

• October 2020, The second version of SONOVEIN, THERACLION's HIFU therapy option for varicose veins, received the CE Mark.

In this report, the Varicose Vein Treatment Market has been segmented by Type, Procedure, End User and Geography.

Varicose Vein Treatment Market, Segmentation by Type

The Varicose Vein Treatment Market has been segmented by Type into Sclerotherapy, Endovenous Ablation and Stripping .

Sclerotherapy

Sclerotherapy dominates with a market share of around 45%, owing to its cost-effectiveness and suitability for small to medium varicose veins. Its minimally invasive nature and high patient satisfaction make it a widely preferred treatment.

Endovenous Ablation

Accounting for approximately 40% of the market, endovenous ablation techniques employ laser or radiofrequency to effectively close diseased veins. These methods offer advantages like minimal scarring and rapid recovery, making them popular among patients and clinicians.

Stripping

Stripping holds about 15% market share and is primarily used for extensive varicose veins or cases unfit for less invasive therapies. Despite being an older surgical method, it remains important in specific clinical scenarios.

Varicose Vein Treatment Market, Segmentation by Procedure

The Varicose Vein Treatment Market has been segmented by Procedure into Injection Sclerotherapy, Endovenous Ablation, and Surgical Ligation/Stripping.

Injection Sclerotherapy

Injection sclerotherapy commands the largest share at around 46%, valued for its non-invasive nature and cost advantages. It effectively treats small to moderate varicose veins, allowing patients to resume daily activities quickly.

Endovenous Ablation

Representing about 39%, endovenous ablation utilizes laser or radiofrequency to seal off problematic veins. Its benefits include minimized pain, faster healing, and better cosmetic outcomes, making it a preferred option.

Surgical Ligation/Stripping

Surgical ligation and stripping hold approximately 15% of the market and remain crucial for severe varicose vein cases. Though more invasive, these procedures ensure comprehensive vein removal and durable results.

Varicose Vein Treatment Market, Segmentation by End User

The Varicose Vein Treatment Market has been segmented by End User into Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), and Others.

Hospitals

Accounting for approximately 45% of the market, hospitals are the primary providers of varicose vein treatments due to their advanced infrastructure and capacity to handle complex cases. They offer a broad range of treatment options, including surgical and minimally invasive procedures.

Specialty Clinics

Specialty clinics hold about 30% share, emphasizing targeted vein care with expert staff and state-of-the-art technologies. Their focus on patient-centric, minimally invasive treatments drives their growing popularity.

Ambulatory Surgical Centers (ASCs)

ASCs comprise nearly 20% of the market, valued for their cost-effective outpatient services and efficient patient throughput. These centers are increasingly preferred for procedures like endovenous ablation and sclerotherapy.

Others

Representing around 5%, the "Others" category includes smaller healthcare facilities and office-based practices that provide accessible vein care, particularly in underserved or rural areas.

Varicose Vein Treatment Market, Segmentation by Geography

In this report, the Global Varicose Vein Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Varicose Vein Treatment Market Share (%), by Geographical Region, 2024

North America

Holding approximately 40% of the market, North America leads due to its sophisticated healthcare infrastructure and widespread use of advanced varicose vein treatments such as endovenous ablation. High patient demand for effective and cosmetic therapies further boosts market growth.

Europe

Europe accounts for about 30% of the market, supported by mature healthcare services and strong governmental focus on vascular health. The preference for minimally invasive outpatient procedures is particularly prominent in Western Europe.

Asia Pacific

Asia Pacific commands close to 20% market share, driven by increasing urban populations and healthcare investments. Countries like China and India are witnessing rising acceptance of varicose vein treatments due to awareness and improved medical facilities.

Middle East and Africa

Comprising nearly 6% of the market, the Middle East and Africa are gradually growing through enhanced healthcare access and the adoption of minimally invasive therapies, although infrastructural limitations persist in some areas.

Latin America

Latin America holds about 4% of the market. Rising awareness, better healthcare infrastructure, and economic growth in countries such as Brazil and Mexico are key factors driving market expansion.

This report provides an in depth analysis of various factors that impact the dynamics of Global Varicose Vein Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Aging population
• Technological advancements
• Rising healthcare expenditure

• Increasing awareness about treatment: The global varicose vein treatment market is experiencing significant growth, driven largely by increasing awareness about available treatment options. Varicose veins, characterized by swollen and twisted veins, affect a considerable portion of the population worldwide. As awareness about the condition and its potential complications grows, more individuals are seeking treatment, thereby propelling market expansion. Moreover, advancements in medical technology and treatment procedures have enhanced the efficacy and safety of varicose vein treatments, further encouraging patients to pursue medical intervention.

  The rising prevalence of risk factors such as obesity, sedentary lifestyles, and aging populations contributes to the escalating demand for varicose vein treatments. With lifestyle-related factors becoming more pervasive globally, the incidence of varicose veins is expected to rise, fueling the market growth for treatment solutions. Furthermore, initiatives undertaken by healthcare organizations and governments to educate the public about the importance of early diagnosis and intervention play a crucial role in boosting awareness levels. By promoting preventative measures and highlighting the availability of effective treatments, these efforts contribute to the overall expansion of the varicose vein treatment market.

  The increasing acceptance of minimally invasive procedures for varicose vein treatment is reshaping the market landscape. Minimally invasive techniques offer several advantages over traditional surgical approaches, including reduced recovery times, minimal scarring, and lower risk of complications. As patients become more inclined towards procedures that offer these benefits, the demand for minimally invasive varicose vein treatments continues to surge. Moreover, technological innovations in this field, such as laser therapy and radiofrequency ablation, are further driving market growth by providing patients with advanced treatment options that deliver optimal outcomes. In conclusion, the global varicose vein treatment market is experiencing robust expansion fueled by growing awareness, the increasing prevalence of risk factors, and the adoption of minimally invasive treatment approaches.

Restraints

• High treatment costs
• Limited reimbursement policies
• Complications associated with procedures

• Lack of skilled professionals: The global varicose vein treatment market is witnessing significant growth, driven by the rising prevalence of varicose veins and the increasing demand for minimally invasive treatment options. However, one of the key challenges faced by this market is the shortage of skilled professionals. Varicose vein treatments, such as endovenous laser ablation, sclerotherapy, and radiofrequency ablation, require specialized training and expertise to ensure safe and effective outcomes.

  The lack of skilled professionals in this field can lead to compromised patient care and outcomes, as inexperienced practitioners may struggle with proper technique and patient management. This shortage is particularly acute in certain regions where access to healthcare education and training programs may be limited. As the demand for varicose vein treatments continues to rise, addressing this shortage of skilled professionals will be crucial for ensuring quality care and meeting the needs of patients worldwide.

  Efforts to address the shortage of skilled professionals in varicose vein treatment may include expanding training programs, offering incentives for healthcare professionals to specialize in this area, and promoting continuing education and skill development opportunities. Collaborative initiatives involving medical societies, educational institutions, and healthcare organizations can also play a key role in increasing the pool of qualified practitioners. By investing in training and education, stakeholders can help alleviate the shortage of skilled professionals in the varicose vein treatment market, ultimately improving patient outcomes and satisfaction.

Opportunities

• Emerging markets
• Minimally invasive procedures
• Strategic collaborations and partnerships

• Growing demand for cosmetic procedures: The global varicose vein treatment market is witnessing significant growth, primarily driven by the increasing demand for cosmetic procedures. Varicose veins, often seen as a cosmetic concern, are becoming more prevalent due to various factors such as sedentary lifestyles, obesity, and aging populations. As people become more conscious of their appearance and seek ways to improve their aesthetics, the demand for treatments to address varicose veins continues to rise.

  Cosmetic procedures for varicose veins offer patients not only aesthetic benefits but also relief from discomfort and pain associated with this condition. Minimally invasive treatments such as sclerotherapy and endovenous laser therapy (EVLT) have gained popularity due to their effectiveness, shorter recovery times, and minimal scarring compared to traditional surgical approaches. Additionally, technological advancements in vein treatment techniques and equipment contribute to the market's growth by providing safer and more efficient solutions for patients.

  The growing acceptance and accessibility of cosmetic procedures worldwide further fuel the expansion of the varicose vein treatment market. With an increasing number of specialized clinics and healthcare facilities offering these services, patients have greater access to treatment options, driving market demand. Moreover, favorable reimbursement policies and insurance coverage for certain varicose vein treatments incentivize patients to seek medical intervention, boosting market growth further. As the trend towards aesthetic enhancement continues to evolve, the global varicose vein treatment market is expected to witness sustained growth in the coming years.

Key players in Global Varicose Vein Treatment Market include:

• Medtronic plc
• AngioDynamics Inc
• Biolitec AG
• Lumenis Ltd
• Syneron Medical Ltd
• Dornier MedTech GmbH
• Alma Lasers Ltd
• Vascular Solutions Inc
• BTG plc
• AngioTech Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis